| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 3530810
[patent_doc_number] => 05583145
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-12-10
[patent_title] => '1-(arylthioalkyl, arylaminoalkyl, or arylmethylenealkyl)-4-(heteroaryl)piperazines and related compounds useful as antipsychotics and analgesics'
[patent_app_type] => 1
[patent_app_number] => 8/466895
[patent_app_country] => US
[patent_app_date] => 1995-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 86535
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 793
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/583/05583145.pdf
[firstpage_image] =>[orig_patent_app_number] => 466895
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/466895 | 1-(arylthioalkyl, arylaminoalkyl, or arylmethylenealkyl)-4-(heteroaryl)piperazines and related compounds useful as antipsychotics and analgesics | Jun 5, 1995 | Issued |
Array
(
[id] => 3582703
[patent_doc_number] => 05580886
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-12-03
[patent_title] => 'Cis-2-[(4-heteroaryl-1 -piperidinyl)alkyl]hexahydro-1H-isoindole-1,3(2H)-diones and related compounds and their therapeutic utility'
[patent_app_type] => 1
[patent_app_number] => 8/469884
[patent_app_country] => US
[patent_app_date] => 1995-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 86396
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 521
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/580/05580886.pdf
[firstpage_image] =>[orig_patent_app_number] => 469884
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/469884 | Cis-2-[(4-heteroaryl-1 -piperidinyl)alkyl]hexahydro-1H-isoindole-1,3(2H)-diones and related compounds and their therapeutic utility | Jun 5, 1995 | Issued |
Array
(
[id] => 3603256
[patent_doc_number] => 05578624
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-11-26
[patent_title] => 'Heteroarylpyrrolidines and their use as antipsychotics and analgesics'
[patent_app_type] => 1
[patent_app_number] => 8/468076
[patent_app_country] => US
[patent_app_date] => 1995-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 86377
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 488
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/578/05578624.pdf
[firstpage_image] =>[orig_patent_app_number] => 468076
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/468076 | Heteroarylpyrrolidines and their use as antipsychotics and analgesics | Jun 5, 1995 | Issued |
Array
(
[id] => 3624122
[patent_doc_number] => 05607945
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-03-04
[patent_title] => 'N-[(4-(heteroaryl)-1-piperidinyl)alkyl]-1,2,3,4-tetrahydroisoquinolines and related compounds and their therapeutic utility'
[patent_app_type] => 1
[patent_app_number] => 8/466821
[patent_app_country] => US
[patent_app_date] => 1995-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 86369
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 725
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/607/05607945.pdf
[firstpage_image] =>[orig_patent_app_number] => 466821
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/466821 | N-[(4-(heteroaryl)-1-piperidinyl)alkyl]-1,2,3,4-tetrahydroisoquinolines and related compounds and their therapeutic utility | Jun 5, 1995 | Issued |
Array
(
[id] => 3662028
[patent_doc_number] => 05624927
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-04-29
[patent_title] => 'N-[4-(heteroaryl)-1-piperazinyl)alkyl]-1,2,3,4-tetrahydroisoquinolines and n-[4(heteroaryl)-1-piperazinyl)alkyl]-1,2,3,4-tetrahydroisoquinolines, related compounds and their therapeutic utility'
[patent_app_type] => 1
[patent_app_number] => 8/466773
[patent_app_country] => US
[patent_app_date] => 1995-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 86359
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 745
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/624/05624927.pdf
[firstpage_image] =>[orig_patent_app_number] => 466773
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/466773 | N-[4-(heteroaryl)-1-piperazinyl)alkyl]-1,2,3,4-tetrahydroisoquinolines and n-[4(heteroaryl)-1-piperazinyl)alkyl]-1,2,3,4-tetrahydroisoquinolines, related compounds and their therapeutic utility | Jun 5, 1995 | Issued |
Array
(
[id] => 3659121
[patent_doc_number] => 05591745
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-01-07
[patent_title] => '(4-heteroaryl)-1-[(2,3-dihydro-1H-isoindol-2-yl)alkyl] piperidines and related compounds and their therapeutic utility'
[patent_app_type] => 1
[patent_app_number] => 8/469365
[patent_app_country] => US
[patent_app_date] => 1995-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 86451
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 624
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/591/05591745.pdf
[firstpage_image] =>[orig_patent_app_number] => 469365
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/469365 | (4-heteroaryl)-1-[(2,3-dihydro-1H-isoindol-2-yl)alkyl] piperidines and related compounds and their therapeutic utility | Jun 5, 1995 | Issued |
Array
(
[id] => 3609302
[patent_doc_number] => 05589495
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-12-31
[patent_title] => '2-[(3-heteroaryl-1-pyrrolidinyl)alkyl]-1,3- indandiones and related compounds and their therapeutic utility'
[patent_app_type] => 1
[patent_app_number] => 8/471515
[patent_app_country] => US
[patent_app_date] => 1995-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 86407
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 621
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/589/05589495.pdf
[firstpage_image] =>[orig_patent_app_number] => 471515
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/471515 | 2-[(3-heteroaryl-1-pyrrolidinyl)alkyl]-1,3- indandiones and related compounds and their therapeutic utility | Jun 5, 1995 | Issued |
Array
(
[id] => 3622573
[patent_doc_number] => 05593995
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-01-14
[patent_title] => '2-[(4-heteroaryl-1-piperazinyl)alkyl]-1,3-indandiones and related compounds and their therapeutic utility'
[patent_app_type] => 1
[patent_app_number] => 8/471514
[patent_app_country] => US
[patent_app_date] => 1995-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 86247
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 638
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/593/05593995.pdf
[firstpage_image] =>[orig_patent_app_number] => 471514
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/471514 | 2-[(4-heteroaryl-1-piperazinyl)alkyl]-1,3-indandiones and related compounds and their therapeutic utility | Jun 5, 1995 | Issued |
Array
(
[id] => 3624285
[patent_doc_number] => 05612343
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-03-18
[patent_title] => 'N-[(4-heteroaryl-1-piperazinyl)alkyl]-2,3-naphthalimides and related compounds and their therapeutic utility'
[patent_app_type] => 1
[patent_app_number] => 8/467912
[patent_app_country] => US
[patent_app_date] => 1995-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 86376
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 599
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/612/05612343.pdf
[firstpage_image] =>[orig_patent_app_number] => 467912
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/467912 | N-[(4-heteroaryl-1-piperazinyl)alkyl]-2,3-naphthalimides and related compounds and their therapeutic utility | Jun 5, 1995 | Issued |
Array
(
[id] => 3636201
[patent_doc_number] => 05610300
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-03-11
[patent_title] => 'Carbocyclic nucleosides containing bicyclic rings, oligonucleotides therefrom, process for their preparation, their use and intermediates'
[patent_app_type] => 1
[patent_app_number] => 8/469045
[patent_app_country] => US
[patent_app_date] => 1995-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16776
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 387
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/610/05610300.pdf
[firstpage_image] =>[orig_patent_app_number] => 469045
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/469045 | Carbocyclic nucleosides containing bicyclic rings, oligonucleotides therefrom, process for their preparation, their use and intermediates | Jun 5, 1995 | Issued |
Array
(
[id] => 3599108
[patent_doc_number] => 05559126
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-09-24
[patent_title] => '1-[(1,4-benodioxanyl)alkyl]-4-(heteroaryl)piperidines and related compounds and their therapeutic utility'
[patent_app_type] => 1
[patent_app_number] => 8/471237
[patent_app_country] => US
[patent_app_date] => 1995-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 86297
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 551
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/559/05559126.pdf
[firstpage_image] =>[orig_patent_app_number] => 471237
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/471237 | 1-[(1,4-benodioxanyl)alkyl]-4-(heteroaryl)piperidines and related compounds and their therapeutic utility | Jun 5, 1995 | Issued |
Array
(
[id] => 3582855
[patent_doc_number] => 05580891
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-12-03
[patent_title] => 'N-[heteroaryl-1-pyrrolidinyl)alkyl]-2-benoxazolinones and related compounds and their therapeutic utility'
[patent_app_type] => 1
[patent_app_number] => 8/471236
[patent_app_country] => US
[patent_app_date] => 1995-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 86514
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 568
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/580/05580891.pdf
[firstpage_image] =>[orig_patent_app_number] => 471236
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/471236 | N-[heteroaryl-1-pyrrolidinyl)alkyl]-2-benoxazolinones and related compounds and their therapeutic utility | Jun 5, 1995 | Issued |
Array
(
[id] => 3609275
[patent_doc_number] => 05589494
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-12-31
[patent_title] => '2-[(3-heteroaryl-1-pyrrolidinyl)alkyl]-1,3-dioxanes and related compounds and their therapeutic utility'
[patent_app_type] => 1
[patent_app_number] => 8/470040
[patent_app_country] => US
[patent_app_date] => 1995-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 86358
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 537
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/589/05589494.pdf
[firstpage_image] =>[orig_patent_app_number] => 470040
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/470040 | 2-[(3-heteroaryl-1-pyrrolidinyl)alkyl]-1,3-dioxanes and related compounds and their therapeutic utility | Jun 5, 1995 | Issued |
Array
(
[id] => 3657190
[patent_doc_number] => 05622950
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-04-22
[patent_title] => 'Pyrrolo-pyridine derivatives'
[patent_app_type] => 1
[patent_app_number] => 8/459993
[patent_app_country] => US
[patent_app_date] => 1995-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20154
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/622/05622950.pdf
[firstpage_image] =>[orig_patent_app_number] => 459993
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/459993 | Pyrrolo-pyridine derivatives | Jun 1, 1995 | Issued |
Array
(
[id] => 3592465
[patent_doc_number] => 05521186
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-05-28
[patent_title] => 'Apolipoprotein-.beta. synthesis inhibitors'
[patent_app_type] => 1
[patent_app_number] => 8/455304
[patent_app_country] => US
[patent_app_date] => 1995-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8747
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 456
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/521/05521186.pdf
[firstpage_image] =>[orig_patent_app_number] => 455304
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/455304 | Apolipoprotein-.beta. synthesis inhibitors | May 30, 1995 | Issued |
Array
(
[id] => 3506729
[patent_doc_number] => 05569659
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-10-29
[patent_title] => '4-arylpiperazines and 4-arylpiperidines'
[patent_app_type] => 1
[patent_app_number] => 8/442600
[patent_app_country] => US
[patent_app_date] => 1995-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15800
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 399
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/569/05569659.pdf
[firstpage_image] =>[orig_patent_app_number] => 442600
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/442600 | 4-arylpiperazines and 4-arylpiperidines | May 16, 1995 | Issued |
Array
(
[id] => 3524888
[patent_doc_number] => 05527786
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-06-18
[patent_title] => 'Phosphonic diester derivatives'
[patent_app_type] => 1
[patent_app_number] => 8/424345
[patent_app_country] => US
[patent_app_date] => 1995-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7109
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/527/05527786.pdf
[firstpage_image] =>[orig_patent_app_number] => 424345
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/424345 | Phosphonic diester derivatives | Apr 18, 1995 | Issued |
Array
(
[id] => 3517519
[patent_doc_number] => 05486518
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-01-23
[patent_title] => '4-indolylpiperazinyl derivatives'
[patent_app_type] => 1
[patent_app_number] => 8/419342
[patent_app_country] => US
[patent_app_date] => 1995-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3129
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/486/05486518.pdf
[firstpage_image] =>[orig_patent_app_number] => 419342
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/419342 | 4-indolylpiperazinyl derivatives | Apr 9, 1995 | Issued |
Array
(
[id] => 3554077
[patent_doc_number] => 05519025
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-05-21
[patent_title] => '4-indolylpiperazinyl derivatives'
[patent_app_type] => 1
[patent_app_number] => 8/419333
[patent_app_country] => US
[patent_app_date] => 1995-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2554
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/519/05519025.pdf
[firstpage_image] =>[orig_patent_app_number] => 419333
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/419333 | 4-indolylpiperazinyl derivatives | Apr 9, 1995 | Issued |
Array
(
[id] => 3614466
[patent_doc_number] => 05565568
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-10-15
[patent_title] => '2-acylaminopropanamides as tachykinin receptor antagonists'
[patent_app_type] => 1
[patent_app_number] => 8/418994
[patent_app_country] => US
[patent_app_date] => 1995-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20744
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 191
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/565/05565568.pdf
[firstpage_image] =>[orig_patent_app_number] => 418994
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/418994 | 2-acylaminopropanamides as tachykinin receptor antagonists | Apr 5, 1995 | Issued |